Articles Tagged With 'OmniScan'
GE Violated Danish Drug Reporting Law in Omniscan Case
Danish drug regulators said that GE's health care unit incompletely informed regulators about a patient who died after experiencing adverse effects from the company's MRI drug Omniscan.
General Electric’s Comments to our Omniscan Stories—and Our Response
GE Healthcare criticizes our stories about Omniscan, and we respond to the criticism.
Judge Opens Door to Case Against General Electric’s Omniscan
A ruling by a Cleveland judge will allow most of the plaintiffs' expert witnesses to testify on GE's MRI drug Omniscan.
GE’s Own Safety Team Urged Company to Restrict MRI Drug
GE Healthcare ignored its own safety experts' urging to restrict the use of its imaging drug, Omniscan, after it was linked to a potentially crippling disease, according to papers in a lawsuit against the company.
GE and Muzzled Radiologist End UK Libel Case
GE Healthcare and a Danish radiologist have settled a British libel suit in which GE claimed that the radiologist had made damaging statements about GE's MRI imaging drug Omniscan.
GE Suit Hushes Scientist Critical of Omniscan
A case over GE's Omniscan MRI drug fuels a debate over British libel law.
FDA Advised to Tighten Restrictions on GE and Covidien MRI Drugs
An FDA advisory panel recommends effectively banning the use of GE’s Omniscan and Covidien’s Optimark in patients with severe kidney disease.
Feds May Tighten Rules on Omniscan, a GE MRI Drug
An FDA review says MRI imaging drugs may be even riskier for kidney patients than it believed previously.
FDA to Take a Second Look at Warnings on MRI Drugs
After issuing a blanket warning about the risk to patients with kidney disease, regulators will reconsider whether to treat some imaging agents differently.
Specter of MRI Disease Haunts GE
Many MRI patients are injected with a GE dye to enhance images. If they have weak kidneys, they might develop a rare and sometimes fatal disease
